# Fibrin for Chronic Multi-level Discogenic Low Back Pain

> **NCT04621799** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Pauza, Kevin, MD** · enrollment: 400 (estimated)

## Conditions studied

- Low Back Pain
- Disc Disease
- Disc Degeneration
- Radiculopathy
- Annular Disc Tear

## Interventions

- **DRUG:** Fibrin sealant

## Key facts

- **NCT ID:** NCT04621799
- **Lead sponsor:** Pauza, Kevin, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-11
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-06-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2020-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04621799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04621799, "Fibrin for Chronic Multi-level Discogenic Low Back Pain". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04621799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*